theophylline has been researched along with Erythrocytosis in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The proposal of this study is to compare the efficacy of lisinopril and theophylline, alone or in association, on erythrocytosis in renal-transplanted patients." | 10.18 | [Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline]. ( Ballestri, M; Bonucchi, D; D'Amelio, A; Mastrangelo, F; Patruno, P, 1997) |
| "Angiotensin converting enzyme inhibitors (ACEI) and theophylline have been reported to decrease the elevated hemoglobin (Hgb) and hematocrit (Hct) levels in the renal transplant recipients with erythrocytosis." | 9.10 | A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis. ( Lal, SM; Trivedi, H, 2003) |
| "Theophylline may have a beneficial effect in treatment and prevention of erythrocytosis in patients with COPD." | 7.69 | Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. ( Beeri, M; Hubert, A; Kramer, MR; Matzner, Y; Oren, R, 1997) |
| "We prospectively evaluated the effects of theophylline, a nonselective adenosine antagonist, in eight patients with erythrocytosis after renal transplantation and in five normal controls." | 7.68 | Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. ( Bakris, GL; Fisher, JW; Gaber, AO; Hussey, JL; Sauter, ER; Winsett, R, 1990) |
| "Theophylline treatment was given to 11 patients." | 5.29 | Erythrocytosis after renal transplantation. The response to theophylline treatment. ( Dranitzki-Elhallel, M; Ilan, Y; Popovtzer, MM; Rubinger, D; Silver, J, 1994) |
| "Angiotensin converting enzyme inhibitors (ACEI) and theophylline have been reported to decrease the elevated hemoglobin (Hgb) and hematocrit (Hct) levels in the renal transplant recipients with erythrocytosis." | 5.10 | A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis. ( Lal, SM; Trivedi, H, 2003) |
| "Posttransplant erythrocytosis (PTE) is a potentially serious complication for which (apart from phlebotomy) two alternative treatments have been proposed: theophylline (Theo) and angiotensin-converting enzyme inhibitors." | 5.08 | Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation. ( Akçiçek, F; Başçi, A; Kürşat, S; Mees, EJ; Ok, E; Töbü, M; Töz, H, 1995) |
| "In a patient with congenital erythropoietin-dependent pure erythrocytosis (EDPE) associated with hypersensitivity of erythroid progenitor cells to erythropoietin (Epo), the investigations planned to elucidate the mechanism responsible for hormone hyperproduction revealed that Epo synthesis was (1) independent of normal oxygen-mediated feedback induced by phlebotomy; (2) not modulated by adenosine as a second messenger (the treatment with the adenosine antagonist theophylline in fact left unchanged the serum Epo levels); and (3) uninfluenced by iron therapy." | 3.69 | Regulation of erythropoietin production in a case of congenital erythropoietin-dependent pure erythrocytosis. ( Barosi, G; Borgna-Pignatti, C; Liberato, NL; Marradi, P; Rosti, V, 1994) |
| "Theophylline may have a beneficial effect in treatment and prevention of erythrocytosis in patients with COPD." | 3.69 | Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. ( Beeri, M; Hubert, A; Kramer, MR; Matzner, Y; Oren, R, 1997) |
| "We prospectively evaluated the effects of theophylline, a nonselective adenosine antagonist, in eight patients with erythrocytosis after renal transplantation and in five normal controls." | 3.68 | Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. ( Bakris, GL; Fisher, JW; Gaber, AO; Hussey, JL; Sauter, ER; Winsett, R, 1990) |
| "Posttransplant erythrocytosis has only been observed in renal transplant recipients and appears to be more frequent with cyclosporine compared with azathioprine therapy." | 2.38 | Posttransplant erythrocytosis: case report and review of newer treatment modalities. ( Bia, MJ; Perazella, MA, 1993) |
| "Theophylline treatment was given to 11 patients." | 1.29 | Erythrocytosis after renal transplantation. The response to theophylline treatment. ( Dranitzki-Elhallel, M; Ilan, Y; Popovtzer, MM; Rubinger, D; Silver, J, 1994) |
| "In vitro cultures of an Epo producing hepatocellular carcinoma (Hep3B) cell line with NECA (> or = 10(-6) M) for 20 hours under hypoxic conditions (1% O2) produced significant increases in medium levels of Epo when compared with hypoxia controls." | 1.29 | Effects of 5'-N-ethylcarboxamideadenosine (NECA) on erythropoietin production. ( Agrawal, KC; Beckman, BS; Brookins, JW; Fisher, JW; Nakashima, J; Ohigashi, T, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 16 (84.21) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prakash, J | 1 |
| Singh, S | 1 |
| Behur, SK | 1 |
| Ghosh, B | 1 |
| Sharatchandra, LK | 1 |
| Dwivedi, US | 1 |
| Trivedi, H | 1 |
| Lal, SM | 1 |
| Ben Hmida, M | 1 |
| Hachicha, J | 1 |
| Jarraya, F | 1 |
| Kharrat, M | 1 |
| Jarraya, A | 1 |
| Grekas, D | 1 |
| Dioudis, C | 1 |
| Valkouma, D | 1 |
| Papoulidou, F | 1 |
| Tourkantonis, A | 1 |
| Ok, E | 1 |
| Akçiçek, F | 1 |
| Töz, H | 1 |
| Kürşat, S | 1 |
| Töbü, M | 1 |
| Başçi, A | 1 |
| Mees, EJ | 1 |
| Borgna-Pignatti, C | 1 |
| Liberato, NL | 1 |
| Marradi, P | 1 |
| Rosti, V | 1 |
| Barosi, G | 1 |
| Ilan, Y | 1 |
| Dranitzki-Elhallel, M | 1 |
| Rubinger, D | 1 |
| Silver, J | 1 |
| Popovtzer, MM | 1 |
| Vereerstraeten, A | 1 |
| Gastaldello, K | 1 |
| Gervy, C | 1 |
| Vanherweghem, JL | 1 |
| Tielemans, C | 1 |
| Nakashima, J | 1 |
| Ohigashi, T | 1 |
| Brookins, JW | 1 |
| Beckman, BS | 1 |
| Agrawal, KC | 1 |
| Fisher, JW | 3 |
| Perazella, MA | 1 |
| Bia, MJ | 1 |
| Gleiter, CH | 1 |
| Oren, R | 1 |
| Beeri, M | 1 |
| Hubert, A | 1 |
| Kramer, MR | 1 |
| Matzner, Y | 1 |
| Yagisawa, T | 1 |
| Toma, H | 1 |
| Yaguchi, H | 1 |
| Tomaru, M | 1 |
| Iijima, Y | 1 |
| Suzuki, H | 1 |
| Nakada, T | 1 |
| Cazzola, M | 1 |
| Guarnone, R | 1 |
| Cerani, P | 1 |
| Rovati, A | 1 |
| Ascari, E | 1 |
| D'Amelio, A | 1 |
| Bonucchi, D | 1 |
| Patruno, P | 1 |
| Ballestri, M | 1 |
| Mastrangelo, F | 1 |
| Krull, F | 1 |
| Bökenkamp, A | 1 |
| Offner, G | 1 |
| Bakris, GL | 1 |
| Sauter, ER | 1 |
| Hussey, JL | 1 |
| Gaber, AO | 1 |
| Winsett, R | 1 |
| Beach, RS | 1 |
| Donlon, D | 1 |
| Escoto, D | 1 |
| McCarthy, J | 1 |
| Napolitano, A | 1 |
| Sosa, R | 1 |
| Ueno, M | 1 |
| Brookins, J | 1 |
| Beckman, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hypervolemia and Treatment Guided by Bioimpedance in End Stage Renal Disease Patients in Zonguldak (Prospective Study)[NCT01468363] | Phase 4 | 550 participants (Anticipated) | Interventional | 2011-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for theophylline and Erythrocytosis
| Article | Year |
|---|---|
Posttransplant erythrocytosis: case report and review of newer treatment modalities.
Topics: Blood Volume; Bloodletting; Combined Modality Therapy; Cyclosporine; Diabetic Nephropathies; Diureti | 1993 |
Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
Topics: Angiotensin-Converting Enzyme Inhibitors; Erythropoietin; Humans; Kidney; Kidney Transplantation; Po | 1996 |
[Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline].
Topics: Cardiotonic Agents; Hematocrit; Humans; Kidney Transplantation; Lisinopril; Polycythemia; Theophylli | 1997 |
3 trials available for theophylline and Erythrocytosis
| Article | Year |
|---|---|
A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Azathioprine; Biomar | 2003 |
Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation.
Topics: Adult; Drug Administration Schedule; Enalapril; Female; Hematocrit; Humans; Kidney Transplantation; | 1995 |
[Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline].
Topics: Cardiotonic Agents; Hematocrit; Humans; Kidney Transplantation; Lisinopril; Polycythemia; Theophylli | 1997 |
14 other studies available for theophylline and Erythrocytosis
| Article | Year |
|---|---|
Early posttransplant erythrocytosis in renal allograft recipients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Follow-Up Studies; Humans; Kidney Transplantation; Male; P | 2010 |
Treatment of post-renal-transplant erythrosis: ACE inhibitors or theophylline?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Humans; Kidney Transplantation; Male; Po | 1995 |
Theophylline modulates erythrocytosis after renal transplantation.
Topics: Adult; Creatinine; Drug Therapy, Combination; Erythropoietin; Female; Hematocrit; Humans; Immunosupp | 1995 |
Regulation of erythropoietin production in a case of congenital erythropoietin-dependent pure erythrocytosis.
Topics: Bloodletting; Cells, Cultured; Erythroid Precursor Cells; Erythropoietin; Humans; Infant; Iron; Male | 1994 |
Erythrocytosis after renal transplantation. The response to theophylline treatment.
Topics: Adult; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Peritonea | 1994 |
High haematocrit in haemodialysis patients can be controlled by theophylline administration.
Topics: Administration, Oral; Arteriovenous Shunt, Surgical; Erythropoietin; Hematocrit; Humans; Kidney Fail | 1994 |
Effects of 5'-N-ethylcarboxamideadenosine (NECA) on erythropoietin production.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Carci | 1993 |
Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.
Topics: Adult; Aged; Bronchodilator Agents; Female; Hematocrit; Humans; Lung Diseases, Obstructive; Male; Mi | 1997 |
Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
Topics: Adenosine; Adult; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Erythropoietin; Humans; Kidne | 1997 |
Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment.
Topics: Adenosine; Adolescent; Erythropoiesis; Erythropoietin; Female; Humans; Polycythemia; Purinergic P1 R | 1998 |
Post-renal transplant erythrocytosis in a child.
Topics: Bloodletting; Child; Erythrocyte Count; Graft Survival; Humans; Kidney Transplantation; Male; Polycy | 1992 |
Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation.
Topics: Adult; Cyclic AMP; Depression, Chemical; Erythropoietin; Female; Hematocrit; Humans; Kidney Transpla | 1990 |
Theophylline for erythrocytosis after renal transplantation.
Topics: Humans; Infant, Newborn; Kidney Transplantation; Polycythemia; Theophylline | 1990 |
A1 and A2 adenosine receptor regulation of erythropoietin production.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Albuterol; Animals; Erythrocytes; Erythropoietin; Fema | 1988 |